Clin Psychopharmacol Neurosci.  2016 May;14(2):218-220. 10.9758/cpn.2016.14.2.218.

Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus

• Mohapatra

• KMID: 2170992
• DOI: http://doi.org/10.9758/cpn.2016.14.2.218

Abstract

Tardive dyskinesia is one of the most significant side effects of antipsychotic medications. Antipsychotic treated schizophrenia patients with diabetes mellitus are more likely to develop tardive dyskinesia than those without diabetes. Clozapine is probably best supported for management of tardive dyskinesia. But clozapine has been strongly linked to hyperglycaemia and impaired glucose tolerance, so it is not preferred in patients with diabetes mellitus. We present a case of 35-year-old male with a diagnosis of schizophrenia and type 2 diabetes mellitus with tardive dyskinesia, who was successfully treated with quetiapine and clonazepam.

Keyword

Movement disorders; Quetiapine; Schizophrenia; Diabetes mellitus

MeSH Terms

Adult
Clonazepam*
Clozapine
Diabetes Mellitus
Diabetes Mellitus, Type 2*
Diagnosis
Glucose
Humans
Male
Movement Disorders*
Schizophrenia*
Quetiapine Fumarate
Clonazepam
Clozapine
Glucose